Safety and Feasibility of a Novel Protocol for Percutaneous Dilatational Tracheostomy in Patients with Respiratory Failure due to COVID-19 Infection: A Single Center Experience

Table 2

Clinical characteristics of COVID-19 patients undergoing PDT.

Variable	PDT patients ()
Age (y)
Gender (male/female)	16/16
Body mass index (kg/m^2)	(min 17-max 66)
PCR positive at the time of PDT	20, 5 false negative
FIO2	(min 30-max 70)
PEEP	(min 5-max 14)
Anticoagulation at the time of PDT	24
ECMO at any time/ECMO at time of PDT	7/0
Days on ventilator before PDT	(min 14-max 39)
Follow-up after PDT (d)	(min 4-max 45)
Follow-up after initial intubation	(min 22-max 72)
Outcome
Weaned from MV	18 (56%)
Remain on MV	5 (16%)
Death	9 (28%)